Nanobiotix (NBTX) News Today $3.70 -0.13 (-3.39%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Nanobiotix’s Market Influence and Innovation UnveiledNovember 14, 2024 | markets.businessinsider.comOptimistic Buy Rating for Nanobiotix: Promising Pipeline Progress and Strategic PartnershipsNovember 14, 2024 | markets.businessinsider.comNanobiotix Strengthens Growth and Financial ProspectsNovember 13, 2024 | markets.businessinsider.comNanobiotix S.A.: NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics PlatformsNovember 12, 2024 | finanznachrichten.deNANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics PlatformsNovember 12, 2024 | globenewswire.comNanobiotix (NASDAQ:NBTX) Trading Up 3.6% - Still a Buy?Nanobiotix (NASDAQ:NBTX) Stock Price Up 3.6% - What's Next?November 6, 2024 | marketbeat.comNANOBIOTIX to Participate in Multiple Investor Conferences in NovemberOctober 31, 2024 | globenewswire.comNanobiotix S.A. ADROctober 18, 2024 | wsj.comNanobiotix S.A. (NASDAQ:NBTX) Short Interest UpdateNanobiotix S.A. (NASDAQ:NBTX - Get Free Report) saw a large drop in short interest in September. As of September 30th, there was short interest totalling 33,300 shares, a drop of 18.0% from the September 15th total of 40,600 shares. Based on an average daily trading volume, of 9,500 shares, the short-interest ratio is currently 3.5 days.October 13, 2024 | marketbeat.comNanobiotix S.A. (NASDAQ:NBTX) Sees Large Drop in Short InterestNanobiotix S.A. (NASDAQ:NBTX - Get Free Report) saw a large drop in short interest during the month of September. As of September 15th, there was short interest totalling 40,600 shares, a drop of 19.4% from the August 31st total of 50,400 shares. Based on an average daily volume of 9,600 shares, the short-interest ratio is presently 4.2 days.September 27, 2024 | marketbeat.comBuy Rating on Nanobiotix: Anticipating Key Data Readouts and Solid FinancialsSeptember 21, 2024 | markets.businessinsider.comNanobiotix S.A.: NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial ResultsSeptember 19, 2024 | finanznachrichten.deNANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial ResultsSeptember 18, 2024 | globenewswire.comNANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term GrowthSeptember 4, 2024 | globenewswire.comNanobiotix to Present at H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | globenewswire.comNanobiotix (NASDAQ:NBTX) Shares Up 8.5%Nanobiotix (NASDAQ:NBTX) Trading 8.5% HigherJuly 31, 2024 | marketbeat.comNanobiotix (NASDAQ:NBTX) Trading Up 1.2%Nanobiotix (NASDAQ:NBTX) Trading Up 1.2%July 6, 2024 | marketbeat.comNanobiotix (NASDAQ:NBTX) Stock Price Down 14%Nanobiotix (NASDAQ:NBTX) Trading Down 14%June 15, 2024 | marketbeat.comNANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024June 12, 2024 | globenewswire.comNanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 TherapyJune 2, 2024 | globenewswire.comNANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference CallMay 28, 2024 | globenewswire.comLeerink Partnrs Comments on Nanobiotix S.A.'s FY2025 Earnings (NASDAQ:NBTX)Nanobiotix S.A. (NASDAQ:NBTX - Free Report) - Leerink Partnrs dropped their FY2025 earnings per share (EPS) estimates for Nanobiotix in a research report issued to clients and investors on Wednesday, May 22nd. Leerink Partnrs analyst J. Chang now expects that the company will post earnings per shMay 24, 2024 | marketbeat.comNANOBIOTIX to Present at the Jefferies Global Healthcare ConferenceMay 23, 2024 | globenewswire.comNanobiotix S.A.: Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term GrowthMay 22, 2024 | finanznachrichten.deNANOBIOTIX Provides First Quarter 2024 Operational and Financial UpdateMay 22, 2024 | globenewswire.comNanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term GrowthMay 21, 2024 | globenewswire.comNANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024May 15, 2024 | globenewswire.comNANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung CancerMay 14, 2024 | globenewswire.comNanobiotix's (NBTX) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating on shares of Nanobiotix in a research report on Friday.April 30, 2024 | marketbeat.comNanobiotix S.A. (NBTX) Q4 2023 Earnings Call TranscriptApril 29, 2024 | seekingalpha.comNanobiotix Stock (NASDAQ:NBTX), Earnings Estimates, EPS, and RevenueApril 26, 2024 | benzinga.comNANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial ResultsApril 24, 2024 | globenewswire.comNANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024April 17, 2024 | globenewswire.comBaillie Gifford & Co. Has $20.89 Million Stock Holdings in Nanobiotix S.A. (NASDAQ:NBTX)Baillie Gifford & Co. increased its position in Nanobiotix S.A. (NASDAQ:NBTX - Free Report) by 48.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,869,030 shares of the company's stock after buying an aApril 11, 2024 | marketbeat.comNanobiotix (NASDAQ:NBTX) Trading Down 1.6%Nanobiotix (NASDAQ:NBTX) Trading Down 1.6%April 3, 2024 | marketbeat.comNanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-IrradiationApril 2, 2024 | globenewswire.comNanobiotix to Present at Upcoming Investor Conferences in MarchMarch 6, 2024 | globenewswire.comNanobiotix S.A. (NASDAQ:NBTX) Shares Bought by Baillie Gifford & Co.Baillie Gifford & Co. raised its holdings in Nanobiotix S.A. (NASDAQ:NBTX - Free Report) by 38.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,936,195 shares of the company's stock after purchaFebruary 17, 2024 | marketbeat.comJohnson & Johnson Buys Shares of 959,637 Nanobiotix S.A. (NASDAQ:NBTX)Johnson & Johnson bought a new stake in Nanobiotix S.A. (NASDAQ:NBTX - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 959,637 shares of the company's stock, valued at approximately $8,397,000.February 12, 2024 | marketbeat.comNanobiotix (NASDAQ:NBTX) Shares Down 2.3% Nanobiotix (NASDAQ:NBTX) Stock Price Down 2.3%February 3, 2024 | marketbeat.comNanobiotix to Present at the Guggenheim 6th Annual Biotechnology ConferenceJanuary 31, 2024 | finance.yahoo.comNanobiotix S.A.: Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer StudyJanuary 30, 2024 | finanznachrichten.deNanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer StudyJanuary 29, 2024 | finance.yahoo.comNBTX Nanobiotix S.A.January 18, 2024 | seekingalpha.comNanobiotix S.A. (NASDAQ:NBTX) Sees Large Increase in Short InterestNanobiotix S.A. (NASDAQ:NBTX - Get Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 35,700 shares, an increase of 113.8% from the December 15th total of 16,700 shares. Based on an average trading volume of 19,000 shares, the days-to-cover ratio is currently 1.9 days.January 12, 2024 | marketbeat.comNanobiotix initiated with an Outperform at LeerinkDecember 8, 2023 | realmoney.thestreet.comNanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.December 4, 2023 | finance.yahoo.comNanobiotix S.A.: NANOBIOTIX Provides Third Quarter 2023 Operational and Financial UpdateNovember 15, 2023 | finanznachrichten.deNANOBIOTIX Provides Third Quarter 2023 Operational and Financial UpdateNovember 13, 2023 | finance.yahoo.comNANOBIOTIX to Announce Third Quarter 2023 Operational and Financial Update on November 13, 2023November 9, 2023 | finance.yahoo.com Get Nanobiotix News Delivered to You Automatically Sign up to receive the latest news and ratings for NBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address [Urgent] Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO. Click here now for the urgent details on this hidden play. NBTX Media Mentions By Week NBTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBTX News Sentiment▼0.000.49▲Average Medical News Sentiment NBTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBTX Articles This Week▼00▲NBTX Articles Average Week Get Nanobiotix News Delivered to You Automatically Sign up to receive the latest news and ratings for NBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cullinan Therapeutics News Today Entrada Therapeutics News Today Tectonic Therapeutic News Today Arbutus Biopharma News Today AnaptysBio News Today Phathom Pharmaceuticals News Today ORIC Pharmaceuticals News Today Exscientia News Today CorMedix News Today Stoke Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NBTX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanobiotix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBTX Stock Alerts